FDA Inspection 1244280 — NOVAVAX CZ a.s.
The FDA completed an inspection of NOVAVAX CZ a.s. on July 18, 2023 in Prague. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 18, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Prague (Czech Republic)